Search

People with a rare type of blood cancer often experience fatigue that is debilitating, distressing and profoundly affects their lives, new Peter Mac-led research has revealed. Myeloproliferative... Read more

Prestigious medical journal The Lancet published a series of papers on the care for cancer survivors this week, with significant contributions from Peter Mac clinician researchers and consumers. The three papers address many... Read more

Read through the following Frequently Asked Questions about PSMA theranostics: I need Lutetium PSMA treatment – can I come to Peter Mac? The... Read more

Re-usable surgical gowns and drapes are being trialled in Peter Mac’s operating theatres, in a move to reduce a major source of clinical waste. The re-usable gowns (worn by the surgical team) and drapes (covering the patient... Read more

Volunteer Services provides a team of highly valued volunteers to support the needs of the Peter Mac Community including patients, their families and loved ones as well as staff.   Our volunteers are integral in... Read more

Melbourne researchers have designed a single drug that delivers a lethal ‘one-two’ punch to several types of blood cancer in preclinical studies and could lead to improved treatments.  The... Read more